Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd
| Jurisdiction | Australia Federal only |
| Court | High Court |
| Judge | French CJ.,Hayne J,Crennan,Kiefel JJ.,Gageler J. |
| Judgment Date | 04 December 2013 |
| Neutral Citation | 2013-1204 HCA A,[2013] HCA 50 |
| Docket Number | S219/2012 & S1/2013 |
| Date | 04 December 2013 |
-
- This document is available in original version only for vLex customers
View this document and try vLex for 7 days - TRY VLEX
- This document is available in original version only for vLex customers
6 cases
-
Alphapharm Pty Ltd v H Lundbeck A/S
...Act. See, generally, Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd (2013) 88 ALJR 261 at 302–303 [186]–[193]; 304 ALR 1 at 51–53; [2013] HCA 50. 79 IPAC Report at 5 80 ‘Government Response to the Report of the Industrial Property Advisory Committee, “Patents, Innovation and Competition ......
-
Australian Financial Services and Leasing Pty Ltd v Hills Industries Ltd
...Australian law: Competition and Consumer Act 2010 (Cth), Sched 2 — Australian Consumer Law, ss 18, 20, 21, 22.See also Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd (2013) 88 ALJR 261 at 270 [17]–[18] per French CJ, 283–284 [71]–[72] per Hayne J; 304 ALR 1 at 9–10, 27; [2013] HCA 50 i......
-
D'Arcy v Myriad Genetics Inc.
...attempt to place upon the idea the fetters of an exact verbal formula could never have been sound.’ Hayne J made it in Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd47: ‘Nothing said in the Court's reasons for decision in that case can be taken as an exact verbal formula which alone capt......
-
InterPharma Pty Ltd v Hospira, Inc (No 5)
...X in the manufacture of a medicament for a specified (and new) therapeutic use”: see Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd [2013] HCA 50; 253 CLR 284 (Apotex v Sanofi-Aventis HCA) at [248]. 32 In Otsuka Pharmaceutical Co Ltd v Generic Health Pty Ltd (No 4) [2015] FCA 634; 113 IP......
Request a trial to view additional results
13 firm's commentaries
-
News from Abroad -- Swiss-type Patent Claims in Australia
...Lambert Company LLC v Generics (UK) Ltd t/a Mylan and another [2018] UKSC 56. [5] Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd [2013] HCA 50. As are claims to therapeutics in ‘when used’ format, which have essentially the same scope as method claims, see Wellcome Foundation Ltd v Commi......
-
News from Abroad: High Court of Australia Hears Myriad Appeal
...Development Corporation v Commissioner of Patents (1959) 102 CLR 252; endorsed by the High Court in Apotex Pty Ltd v Sanofi Aventis [2013] HCA 50. 4 IPTA Submissions at [34]. 5 Attorney-General's Submissions at [6]. 6 Ibid at [10]. 7 Association for Molecular Pathology v Myriad Genetics 569......
-
Methods of medical treatment patentable in Australia; infringement by cross-label use is fact-dependent
...demonstrate that indirect infringement will depend on the facts in each case (Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd [2013] HCA 50). Sanofi's psoriasis compound and Apotex's Sanofi-Aventis Deutschland GmbH was the registered owner of a patent which claimed a method of preventing ......
-
The High Court gives generics the rubber-stamp for 'skinny labelling' (but no surprises on method of treatment patents)
...Apotex v Sanofi-Aventis [2013] HCA 50 the High Court finally confirmed (what was fairly well understood all along) that methods of medical treatment are patentable subject matter in Australia. However, it remains uncertain whether medical/surgical procedures are patentable. The High Court's......
Request a trial to view additional results